Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11786559 Blood-brain barrier comprising engineered endothelial cells

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 13, 2017
Date of Patent
October 17, 2023
Patent Applicant
‌
Angiocrine Bioscience, Inc.
Patent Application Number
16332634
Patent Citations
‌
US Patent 8465732 Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
‌
US Patent 9637723 Generation of functional and durable endothelial cells from human amniotic fluid-derived cells
‌
US Patent 10113149 Reprogramming of human endothelium into hematopoietic multi-lineage progenitors by defined factors
‌
US Patent 10877026 Blood brain barrier models and methods to generate and use the same
‌
US Patent 10946066 Methods for organ regeneration
‌
US Patent 10961509 Engineered endothelial cells expressing an ETS transcription factor
‌
US Patent 10947500 Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
‌
US Patent 6852533 Purified populations of stem cells
‌
US Patent 7396680 Stem cell-specific promoters and their use
‌
US Patent 8084254 Human blood brain barrier model
•••
Patent Inventor Names
Daniel Joseph Nolan
Liang Qiang
Michael Daniel Ginsberg
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11786559
Patent Primary Examiner
‌
Allison M Fox

Find more entities like US Patent 11786559 Blood-brain barrier comprising engineered endothelial cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo